European Archives - Page 23 of 1531 - European Medical Journal

Triple Immunotherapy Shows No Added Benefit in Unresectable HCC

A phase 2 trial found that adding low-dose ipilimumab to atezolizumab and bevacizumab did not improve response rates in unresectable liver cancer.

Patient in Scotland Tests Negative for Ebola

A patient in Scotland has tested negative for Ebola disease, Public Health Scotland has reported.

Septal ECV Marker May Identify Advanced AV Block in Myocarditis

CMR findings suggest elevated septal ECV may help distinguish advanced atrioventricular block in acute myocarditis and identify patients at risk of adverse outcomes.

EMJ Neurology 14.1 [Supplement 2] 2026

Myasthenia gravis (MG) care is evolving rapidly, driven by innovative treatments and a growing recognition of the condition’s impact…

Myasthenia Gravis in Transition

Myasthenia gravis treatment is evolving, with new therapies improving outcomes and quality of life. However, delayed diagnosis, unmet…

EMJ Neurology 14 [Supplement 1] 2026

New real-world evidence for efgartigimod in chronic inflammatory demyelinating polyneuropathy (CIDP) presented at the AAN and PNS…

IgG-targeted CIDP therapy

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare and severe immune-mediated disease that affects sensory function and…

Where Oncology Meets Public Policy

In this series, host Jonathan Sackier speaks with Professor Christopher Cogle about the intersection of oncology, healthcare systems, and…

percutaneous coronary intervention

Imaging-Guided PCI Improves Outcomes in Coronary Disease

A meta analysis of five randomised trials found that intravascular imaging-guided PCI reduced major adverse cardiovascular events in patients with multivessel coronary artery disease.

Ester in ’t Groen, Johnson & Johnson Innovative Medicine

One to watch: Multiple myeloma at EHA 2026

Ester in ’t Groen, TA Head, Haematology, J&J Innovative Medicine, discusses how treatment advances are transforming care.